Association of circulating ANGPTL3 level with all-cause and cardiovascular mortality
Angiopoietin-like protein 3 (ANGPTL3) is a liver-derived regulator of triglyceride and cholesterol metabolism and has emerged as a notable therapeutic target for dyslipidemia [1]. However, population-level evidence linking ANGPTL3 level to mortality outcomes remains limited. Using data from UK Biobank [2], we evaluated...